Oncology billing and revenue cycle for New Jersey providers.
New Jersey operates 581 oncology billing organizations registered in NPPES, representing 4.3 percent of the U.S. oncology billing footprint. New Jersey is a mid-sized oncology billing market. Oncology revenue cycle complexity centers on infusion administration code stacking, drug J-code and ASP+6 reimbursement, NCCN-aligned prior authorization, and oncology-specific E/M leveling. New Jersey oncology practices need RCM partners with deep infusion + drug billing experience.
What good oncology billing execution looks like for New Jersey providers.
The New Jersey oncology billing market has its own quirks. Here is the operating discipline we install on every New Jersey engagement.
- Infusion and chemotherapy administration code accuracyOncology infusion billing requires precise capture of initial, sequential, concurrent, and additional hour codes (96360-96376, 96401-96450, J-codes for drugs). New Jersey infusion centers leak revenue on undercoded administration time.
- J-code drug pricing and ASP+6 reimbursementOncology drugs reimburse under Medicare at Average Sales Price + 6 percent (Part B), with similar logic on many commercial. New Jersey oncology practices need accurate J-code billing, NDC reporting, and ASP-aware revenue forecasting.
- Prior authorization for oncology drugsSpecialty oncology drugs require payer prior authorization, often with clinical criteria tied to NCCN guideline alignment. PA automation tuned for oncology compresses access-to-treatment time and reduces denials.
- E/M leveling for oncology visitsOncology visits qualify for higher E/M levels under MDM complexity rules. New Jersey oncology practices that under-level E/M leave significant revenue uncollected.
- OCM and Enhancing Oncology Model participationPractices in the CMS Enhancing Oncology Model (EOM) coordinate clinical, financial, and reporting workflows for value-based payment. New Jersey EOM participants need RCM that flows into program reporting.
- 340B drug pricing for eligible oncology entitiesFQHC + DSH-eligible hospital oncology practices in 340B require precise inventory tracking, contract pharmacy coordination, and proper claim modification (TB modifier).
FAQ: oncology billing in New Jersey.
How many oncology billing providers operate in New Jersey?
NPPES lists 581 oncology billing organizations in New Jersey, representing 4.3% of the U.S. footprint. Top concentrations are in Jersey City (25), Toms River (18), Cherry Hill (16).
Does NJ FamilyCare cover oncology billing services?
Yes. NJ FamilyCare covers oncology billing services for eligible beneficiaries, with plan-specific authorization rules and rate structures that vary by year.
What commercial payers cover oncology billing in New Jersey?
All major national commercial payers cover oncology billing in New Jersey, including UnitedHealthcare/Optum, Aetna, Cigna/Evernorth, the dominant New Jersey Blue Cross Blue Shield plan, and (where active) Humana.
Does ASP-RCM serve oncology billing providers in New Jersey?
Yes. ASP-RCM Solutions provides oncology billing and revenue cycle services for providers in New Jersey and across all 50 states. Senior partners on every account. Request a free 30-day audit.
How do I get started?
Request a free 30-day RCM audit. We assess your current state, identify revenue leakage, and produce a written prioritized recommendations list.